CAR T-Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type (CD19 - Targeted,BCMA - Targeted), By Application (Lymphoma,Multiple Myeloma), Regional Insights and Forecast to 2035

Detailed TOC of Global CAR T-Cell Therapy Market Growth (Status and Outlook) 2025-2031

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size (2020-2031)
2.1.2 CAR T-Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CAR T-Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 CAR T-Cell Therapy Segment by Type
2.2.1 CD19 - Targeted
2.2.2 BCMA - Targeted
2.3 CAR T-Cell Therapy Market Size by Type
2.3.1 CAR T-Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CAR T-Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 CAR T-Cell Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-Cell Therapy Market Size by Application
2.5.1 CAR T-Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CAR T-Cell Therapy Market Size Market Share by Application (2020-2025)
3 CAR T-Cell Therapy Market Size by Player
3.1 CAR T-Cell Therapy Market Size Market Share by Player
3.1.1 Global CAR T-Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-Cell Therapy by Region
4.1 CAR T-Cell Therapy Market Size by Region (2020-2025)
4.2 Global CAR T-Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR T-Cell Therapy Market Size Growth (2020-2025)
4.4 APAC CAR T-Cell Therapy Market Size Growth (2020-2025)
4.5 Europe CAR T-Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR T-Cell Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas CAR T-Cell Therapy Market Size by Country (2020-2025)
5.2 Americas CAR T-Cell Therapy Market Size by Type (2020-2025)
5.3 Americas CAR T-Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Therapy Market Size by Region (2020-2025)
6.2 APAC CAR T-Cell Therapy Market Size by Type (2020-2025)
6.3 APAC CAR T-Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size by Country (2020-2025)
7.2 Europe CAR T-Cell Therapy Market Size by Type (2020-2025)
7.3 Europe CAR T-Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR T-Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR T-Cell Therapy Market Forecast
10.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas CAR T-Cell Therapy Forecast
10.1.3 APAC CAR T-Cell Therapy Forecast
10.1.4 Europe CAR T-Cell Therapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Therapy Forecast
10.2 Americas CAR T-Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market CAR T-Cell Therapy Forecast
10.2.2 Canada Market CAR T-Cell Therapy Forecast
10.2.3 Mexico Market CAR T-Cell Therapy Forecast
10.2.4 Brazil Market CAR T-Cell Therapy Forecast
10.3 APAC CAR T-Cell Therapy Forecast by Region (2026-2031)
10.3.1 China CAR T-Cell Therapy Market Forecast
10.3.2 Japan Market CAR T-Cell Therapy Forecast
10.3.3 Korea Market CAR T-Cell Therapy Forecast
10.3.4 Southeast Asia Market CAR T-Cell Therapy Forecast
10.3.5 India Market CAR T-Cell Therapy Forecast
10.3.6 Australia Market CAR T-Cell Therapy Forecast
10.4 Europe CAR T-Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market CAR T-Cell Therapy Forecast
10.4.2 France Market CAR T-Cell Therapy Forecast
10.4.3 UK Market CAR T-Cell Therapy Forecast
10.4.4 Italy Market CAR T-Cell Therapy Forecast
10.4.5 Russia Market CAR T-Cell Therapy Forecast
10.5 Middle East & Africa CAR T-Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market CAR T-Cell Therapy Forecast
10.5.2 South Africa Market CAR T-Cell Therapy Forecast
10.5.3 Israel Market CAR T-Cell Therapy Forecast
10.5.4 Turkey Market CAR T-Cell Therapy Forecast
10.6 Global CAR T-Cell Therapy Forecast by Type (2026-2031)
10.7 Global CAR T-Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CAR T-Cell Therapy Forecast
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-Cell Therapy Product Offered
11.1.3 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-Cell Therapy Product Offered
11.2.3 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Offered
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-Cell Therapy Product Offered
11.4.3 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-Cell Therapy Product Offered
11.5.3 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-Cell Therapy Product Offered
11.6.3 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Information
11.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Information
11.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Information
11.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mustang Bio(Pipeline) Main Business Overview
11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Information
11.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bluebird Bio(Pipeline) Main Business Overview
11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Information
11.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Offered
11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cellectis(Pipeline) Main Business Overview
11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Information
11.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Information
11.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Offered
11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Celyad(Pipeline) Main Business Overview
11.14.5 Celyad(Pipeline) Latest Developments
12 Research Findings and Conclusion